Navigation Links
United BioSource Expands Regulatory Affairs Capabilities
Date:2/25/2008

Former Pfizer executives to lead regulatory affairs group based in Ann

Arbor, Michigan

BETHESDA, Md., Feb. 25 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the expansion of its Regulatory Affairs group led by distinguished experts Mark Ammann, Pharm.D. and LaVonne Lang, Dr PH. Based in Ann Arbor, Michigan, the group will provide a full range of services to pharmaceutical and biotechnology clients, including creating and implementing development plans to fulfill regulatory requirements for initial approval of new medicines and providing life-cycle management for marketed products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

The Regulatory Affairs group will be headed by Dr. Mark Ammann, a 17-year veteran of the pharmaceutical industry, who has worked with products from early development to post-marketing product support in such diverse therapeutic areas as CNS, oncology, dermatology, inflammation, endocrinology and cardiovascular disorders. Dr. Ammann most recently held the position of Global Head of Regulatory Affairs at Pfizer Corporation where he was responsible for several therapeutic areas including central nervous system, inflammation and dermatology.

"We are thrilled to welcome Dr. Ammann and Dr. Lang to the UBC team. They give us world-class experience and expertise in navigating through the drug development process with the FDA. This capability complements our specialized regulatory knowledge in areas like health outcomes and post-approval research to provide clients unique regulatory insight in both the pre- and post- approval environment," according to Ethan Leder, UBC CEO and Founder.

"Having led many interactions with the FDA over the past 16 years, I am particularly excited about helping clients navigate through the maze of evolving regulations, offering them counsel about the impact of these changes to their programs," says Dr. Ammann.

Dr. LaVonne Lang will join Ammann in a leadership role, serving as Senior Director, Regulatory Affairs. Dr. Lang has 18 years of experience in pharmaceutical development, with 12 years in positions of increasing responsibility in regulatory strategy at Parke-Davis and Pfizer.

The group will conduct cradle-to-grave global strategic planning, manage submission and liaison activities with health authorities and handle medical writing of regulatory documents. As part of its mandate, they will offer services to both emerging and established life science companies.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Eastern and Western Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Mark Ammann, PharmD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73619 LaVonne Lang, Dr PH http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73620


'/>"/>
SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
2. United States Patent Office Grants CryoCors Request for Patent Interference
3. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
4. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
5. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
6. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
7. Neptune Technologies receives GRAS notification in the United States
8. Essilor: New Acquisitions in the United States and Brazil
9. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
10. Medical Services Begins Working With United States Companies for Distribution of Its Products
11. United Therapeutics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... May 19, 2017 , ... The University City ... with technologies ripe for commercialization, and who are affiliated with the 21 partner ... submit proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), ... as the company continues to grow. CSM has doubled in size over the ... executing an aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. ...
(Date:5/18/2017)... ... 2017 , ... Cognition Corporation ( http://www.cognition.us ), ... version 9.0 of the Cognition Cockpit platform. , “Our whole team has put ... CEO of Cognition. “We’re thrilled to finally be able to release it to ...
(Date:5/18/2017)... , ... May 17, 2017 , ... ... announced today that their Chief Executive Officer, Maik Jornitz, was recognized as a ... publication’s Power List celebrates 100 individuals “involved in bettering the pharma industry and ...
Breaking Biology Technology:
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):